EGA
ACER

Eagle Global Advisors’s Acer Therapeutics Inc ACER Stock Holding History

Eagle Global Advisors’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,687
Closed -$65K – 399
2016
Q1 		$65K Buy
+2,687
New +$58.9K ﹤0.01% 361

Other funds holding ACER

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Eagle Global Advisors's ACER Position: Q2 2016 in Review

Eagle Global Advisors sold out of Acer Therapeutics Inc (ACER) in Q2 2016, closing a stake of 2,687 shares — an estimated $65K sold.

Eagle Global Advisors first reported a position in ACER in Q1 2016 and held it in 1 quarter. The position peaked at $65K in Q1 2016. 11 funds tracked by Wall St. Rank hold ACER as of Q2 2016.

  • Eagle Global Advisors reported no remaining Acer Therapeutics Inc position as of Q2 2016 after selling out during the quarter.
  • Eagle Global Advisors sold 2,687 Acer Therapeutics Inc shares in Q2 2016, an estimated $65K.
  • Eagle Global Advisors first reported a position in Acer Therapeutics Inc in Q1 2016 and held it in 1 quarter.
  • Eagle Global Advisors's Acer Therapeutics Inc position peaked at $65K in Q1 2016.
  • 11 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2016.

Based on Eagle Global Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.